Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately. Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Trending
- Citing former PM Manmohan Singh, BJP says Congress has habit of discrediting Election Commission
- Anti-graft bills not aimed at undercutting non-BJP governments, says ministry of home affairs
- Supreme Court seeks Ram mandir fund probe status report in a week
- ‘Comprehensive sex education’ coming soon to schools, govt tells Supreme Court
- Did Erling Haaland really bring a raccoon home? Here’s the truth
- India launches UNSC campaign for 2028-29 term, Jaishankar unveils ‘SHANTI’ vision
- Quote of the day by Justin Trudeau: ‘I don’t read the newspapers, I don’t watch the news. I figure, if something important happens, someone will tell me’ and his detachment from politics
- Supreme Court quashes Guwahati high court order on 27 ‘foreigners’